quoted from here
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Monday, May 11, 2015
Question of the Day May 11, 2015 “Patients have a right to unbiased information from their pharmacy about their medications,” said Attorney General Schneiderman. “Drug companies cannot pay pharmacies to promote drugs directly to patients.” If the federal government grant pharmacists provider status will those pharmacist be prohibited by current or future law from recommending a compounded medication made by their own pharmacy since they will have financial interest in promoting compounded drugs made by them? Why or why not? What is the solution to prevent these types of conflicts of interest if pharmacists are granted provider status and wish to be both a provider and a compounding pharmacist?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment